- The stock has been in a strong uptrend, forming higher highs and higher lows, confirming a bullish trend.
- A significant liquidity zone was created around INR 320 during the election results day, providing a solid support level.
- The stock is currently trading near the 0.5 Fibonacci retracement level at INR 422, which is a crucial resistance level.
- Breaking above this level with volume can lead to further upside, targeting the 0.618 Fibonacci level and higher.
- Recent price movements are supported by increasing volume, indicating strong buying interest.
- The volume spike on the breakout above the trendline signifies the strength of the upward movement.
- Immediate resistance is at INR 422, which aligns with the 0.5 Fibonacci retracement level.
- Support levels are at INR 380 and the trendline support at around INR 320.
- The RSI is currently above 50, indicating bullish momentum.
- The RSI needs to maintain above 50 to sustain the bullish trend.
- The latest quarterly earnings report showed a significant increase in revenue and profit margins, driven by higher demand and improved operational efficiencies.
- The company reported a revenue growth of 18% YoY and a net profit increase of 22% YoY.
- Supriya Lifescience recently announced the expansion of its manufacturing facilities, which is expected to increase production capacity by 30%.
- The company has secured several new contracts from major pharmaceutical companies, enhancing its revenue visibility.